Answers are grounded in this paper and cite their sources.
Ultrasound-activatable nanodroplets represent a class of agents for diagnostic and therapeutic applications, but most formulations use synthetic stabilizing shells. Here, we describe a proof-of-concept platform in which erythrocyte-derived whole-cell/ghost structures serve as biomimetic carriers for perfluorocarbon (PFC) nanodroplets. Naked (surfactant-free) nanodroplets of perfluorobutane (PFB), perfluoropentane (PFP), and perfluorohexane (PFH) were fabricated using a simplified Ouzo emulsification method and combined with erythrocytes by deep-freeze processing. Bright-field and confocal fluorescence microscopy provided supportive qualitative evidence of droplet-like PFC-associated structures within projected cell contours and at erythrocyte membranes. Upon ultrasound exposure in a gel phantom, the treated erythrocyte preparations generated bubbles, with lower apparent activation pressures for the more volatile PFCs. We propose, as a working hypothesis, that freeze-thaw injury may facilitate droplet entry or association through transient membrane defects; ice-crystal-induced membrane disruption, ethanol-induced membrane fluidization, osmotic stress, and other freeze-thaw effects may all contribute. These preliminary findings establish feasibility while leaving loading efficiency, membrane integrity, biological function, stability, and in vivo performance to be quantified in future studies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: